Putnam Investments’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Putnam Investments’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,399	Closed	-$1M	–	1232
2022 Q3	$1M	Buy	+50,399	New	+$665K	﹤0.01%	850

Putnam Investments's FMTX Position: Q4 2022 in Review

Putnam Investments sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 50,399 shares — an estimated $1M sold.

Putnam Investments first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $1M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Putnam Investments reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Putnam Investments sold 50,399 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1M.
Putnam Investments first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Putnam Investments's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.